Skip to main content

Advertisement

ADVERTISEMENT

Volume 32 - Issue 12 - December, 2020

December 2020 Table of Contents
12/01/2020
December 2020 Table of Contents and Whole Issue PDF
December 2020 Table of Contents and Whole Issue PDF
December 2020 Table of Contents...
12/01/2020
Journal of Invasive Cardiology
Impact of Sex on Outcomes Among Patients With Cardiac Allograft Vasculopathy Who Undergo Percutaneous Coronary Intervention
12/01/2020

Michael S. Lee, MD1; Subeer K. Wadia, MD1; Richard Shlofmitz, MD²

Michael S. Lee, MD1; Subeer K. Wadia,...
Orthotopic heart transplantation is a reasonable treatment strategy for patients with end-stage heart failure. Percutaneous coronary intervention (PCI) can be performed to treat cardiac allograft vasculopathy (CAV). We sought to examine...
Orthotopic heart transplantation is a reasonable treatment strategy for patients with end-stage heart failure. Percutaneous coronary intervention (PCI) can be performed to treat cardiac allograft vasculopathy (CAV). We sought to examine...
Orthotopic heart transplantation...
12/01/2020
Journal of Invasive Cardiology
Feasibility and Safety of Performing Complex  Coronary Interventions by Distal Radial Artery Using the Railway Sheathless Vascular System
12/01/2020

Giuseppe Colletti, MD1; Jacques Auslender, MD1; Antoine De Meester, MD1; Adel Aminian, MD2; Peter Kayaert, MD3; Claudiu Ungureanu, MD1

Giuseppe Colletti, MD1; Jacques Ausle...
The aim of this clinical study is to assess the feasibility and safety of the 7 Fr Railway sheathless access system (Cordis Corporation) for complex PCI using distal radial artery access.
The aim of this clinical study is to assess the feasibility and safety of the 7 Fr Railway sheathless access system (Cordis Corporation) for complex PCI using distal radial artery access.
The aim of this clinical study...
12/01/2020
Journal of Invasive Cardiology
Comparative Intermediate-Term Outcomes of Subclavian and Transcaval Access for Transcatheter Aortic Valve Replacement
12/01/2020

Ashleigh Long, MD, PhD and Paul Mahoney, MD

Ashleigh Long, MD, PhD and Paul Mahon...
We compared the procedural efficacy and outcomes at 30 days and 1 year in patients who underwent TAVR via subclavian (or transcaval access route at a single, tertiary-care center.
We compared the procedural efficacy and outcomes at 30 days and 1 year in patients who underwent TAVR via subclavian (or transcaval access route at a single, tertiary-care center.
We compared the procedural...
12/01/2020
Journal of Invasive Cardiology
Caval Valve Implantation for Tricuspid Regurgitation: Insights From the United States Caval Valve Registry
12/01/2020

Brian P. O’Neill, MD1; Sara Negrotto, MD2; Daohai Yu, PhD3; Vladimir Lakhter, DO3; Jeremiah Depta, MD4; James M. McCabe, MD5; Sandeep Dube, MD6; Mahadevan Vaikom, MD7; Dee Dee Wang, MD1; Pravin Patil, MD3; Brian Lindman, MD2; Ignacio Iglessis-Azuaje, MD8; Joseph Fredi, MD9; Xiaoning Lu, MS3; William W. O’Neill, MD1 

Brian P. O’Neill, MD1; Sara Negrotto,...
We sought to describe the outcomes of patients who underwent caval valve implantation (CAVI) for treatment of severe tricuspid regurgitation in the United States. Previous studies on CAVI have used a variety of techniques and transcatheter...
We sought to describe the outcomes of patients who underwent caval valve implantation (CAVI) for treatment of severe tricuspid regurgitation in the United States. Previous studies on CAVI have used a variety of techniques and transcatheter...
We sought to describe the...
12/01/2020
Journal of Invasive Cardiology
Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair
12/01/2020

Ozan M. Demir, MBBS1*; Martina Maria Ruffo, MD1*; Cosmo Godino, MD2; Marco Ancona, MD1; Francesco Ancona, MD3; Stefano Stella, MD3; Andrea R. Munafó, MD2; Antonio Sisinni, MD2; Eustachio Agricola, MD3; Antonio Colombo, MD1; Alaide Chieffo, MD1; Matteo Montorfano, MD1

*Joint first authors

Ozan M. Demir, MBBS1*; Martina Maria ...
Approximately 50% of patients with severe mitral regurgitation referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term...
Approximately 50% of patients with severe mitral regurgitation referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term...
Approximately 50% of patients...
12/01/2020
Journal of Invasive Cardiology
Selective Coronary Artery Angiography in Hypoplastic Left Heart Syndrome
12/01/2020

Sruti Rao, MD1,2; Geetha Challapudi, MD1,3; Neha Chellu1; Salima Bhimani, MD1; Lourdes Prieto, MD4; Rukmini Komarlu, MD1

Sruti Rao, MD1,2; Geetha Challapudi, ...
Coronary artery disease in palliated hypoplastic left heart syndrome is uncommon. We sought to assess and describe coronary artery involvement in this complex patient population. Our research highlights both the need to assess distal coronary...
Coronary artery disease in palliated hypoplastic left heart syndrome is uncommon. We sought to assess and describe coronary artery involvement in this complex patient population. Our research highlights both the need to assess distal coronary...
Coronary artery disease in...
12/01/2020
Journal of Invasive Cardiology
Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry
12/01/2020

Vincenzo De Marzo, MD1,2; Rosario Parisi, MD3; Marco Caruso, MD4; Domenico D’Amario, MD, PhD5; Gianmarco Annibali, MD5; Vincenzo Manganiello, MD6; Rocco Vergallo, MD, PhD5; Michael Donahue, MD7; Pio Cialdella, MD7; Alfonso Ielasi, MD8; Leonardo Misuraca, MD9; Luca Altamura, MD10; Bernardo Cortese, MD11; Claudio Larosa, MD12; Marco Canepa, MD, PhD1,2; Italo Porto, MD, PhD1,2

Vincenzo De Marzo, MD1,2; Rosario Par...
Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...
Our objective was to evaluate the safety and efficacy of the Orsiro sirolimus-eluting stent (Biotronik) in patients with ST-segment elevation myocardial infarction undergoing primary PCI. Specific drug-eluting stent platforms might influence...
Our objective was to evaluate...
12/01/2020
Journal of Invasive Cardiology
The Safety and Feasibility of Transitioning From Transfemoral to Transradial Access Left Ventricular Endomyocardial Biopsy
12/01/2020

Zaccharie Tyler, MBBS1; Oliver P. Guttmann, MRCP(UK)1,2; Mehul Dhinoja, MRCP(UK)1; Rodnie Oro, BSc1; Konstantinos Savvatis, MD, PhD1,2; Saidi Mohiddin, FRCP(UK)1,2; Neha Sekhri, FRCP(UK)1,2; Luis Lopes, MD1,2; Vimal Patel, MD(Res), MRCP(UK)1; Daniel A. Jones, MRCP(UK)1; Christos V. Bourantas, MD, PhD1; Anthony Mathur, FRCP(UK), PhD1; Perry M. Elliott, MD, FRCP(UK)1,2; Constantinos O’Mahony, MD(Res), FRCP(UK)1,2

Zaccharie Tyler, MBBS1; Oliver P. Gut...
Left ventricular endomyocardial biopsy (LVEMB) is commonly performed via the transfemoral route. Radial access may help reduce vascular access complications, but there are few data on the safety and feasibility of transradial LVEMB. We...
Left ventricular endomyocardial biopsy (LVEMB) is commonly performed via the transfemoral route. Radial access may help reduce vascular access complications, but there are few data on the safety and feasibility of transradial LVEMB. We...
Left ventricular endomyocardial...
12/01/2020
Journal of Invasive Cardiology
Impact of Rapid Ventricular Pacing During Transcatheter Implantation of Self-Expanding Aortic Valve Prostheses in Patients at Highest Risk
12/01/2020

Ulrich Fischer-Rasokat, MD, PhD1; Matthias Renker, MD1,2,5; Christoph Liebetrau, MD, PhD1,3,5; Helge Möllmann, MD, PhD4; Christian W. Hamm, MD, PhD1,3,5; Won-Keun Kim, MD1,2,3

Ulrich Fischer-Rasokat, MD, PhD1; Mat...
Patients with low-flow, low-gradient (LFLG) aortic stenosis (AS) have the highest risk among all AS patients. We investigated the effects of rapid ventricular pacing in patients with LFLG-AS.
Patients with low-flow, low-gradient (LFLG) aortic stenosis (AS) have the highest risk among all AS patients. We investigated the effects of rapid ventricular pacing in patients with LFLG-AS.
Patients with low-flow,...
12/01/2020
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement